Beijing Konruns Pharmaceutical Co.,Ltd. (603590.SS) SHH
32.81
-1.38(-4.04%)
Currency In CNY
- General
- Statistics
- Historical Data
- Profile
- Financials
Beijing Konruns Pharmaceutical Co.,Ltd.
Sector
Healthcare
Industry
Biotechnology
Employees
668
First IPO Date
September 03, 2018
Key Executives
| Name | Title | Pay | Year Born |
| Xiao Dong Huang | Secretary to the Board | 0 | N/A |
| Jing Wang | Accounting Supervisor | 0 | N/A |
| Zhanqi Niu | President & Director | 0 | 1968 |
| Xiaohan Liu | Chief Financial Officer & Director | 0 | 1989 |
Description
Beijing Konruns Pharmaceutical Co.,Ltd. engages in the research, production, and sale of various drugs in China. The company offers Su Ling product in the hemagglutinin preparation market used to reduce bleeding during surgery and control postoperative surgery. It also engages in the development of drug candidates, including CX1026, CX1003, and KC1036. The company was founded in 2003 and is headquartered in Beijing, China.
